Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Akimoto

Showing results (191-200 of 299) with videos related to

Pageof 30
Sort By:
Genes, Chromosomes & Cancer|October 28, 1998
Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancersK Ohgaki, A Iida, F Kasumi, et al.
Arzneimittel-Forschung|April 1, 1986
Intestinal absorption enhancement of coenzyme Q10 with a lipid microsphereY Ozawa, Y Mizushima, I Koyama, et al.
Cancer Detection and Prevention|January 1, 1986
Assessment of host immune response in breast cancer patientsM Akimoto, H Ishii, Y Nakajima, et al.
Biochemical Pharmacology|January 22, 2000
Modulation of telomerase activity by zinc in human prostatic and renal cancer cellsK Nemoto, Y Kondo, S Himeno, et al.
IUBMB Life|January 19, 2000
Effect of 13-hydroperoxyoctadecadienoic acid on the supply of arachidonic acid for prostaglandin synthesis from arachidonoyl-CoA mediated by the cytosolic or microsomal acyl-CoA hydrolase in rabbit kidney medullaS Sakuma, Y Fujimoto, M Yoshimura, et al.
Nihon Geka Gakkai Zasshi|January 1, 1991
[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]M Akimoto, T Nishihira, H Hirakawa, et al.
Urology|August 30, 2000
High-frequency endoluminal ultrasonography for staging transitional cell carcinoma of the bladderK Horiuchi, N Tsuboi, H Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1984
[Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)]M Akimoto, H Ueki, Y Nakajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[The effect of an arginine-imbalanced diet on the growth of implanted MM-48 and MH-134 tumors in C3H/He mice]M Akimoto, Y Nakajima, H Iwasaki, et al.
Clinical Pharmacology and Therapeutics|May 29, 2000
Population pharmacokinetics and pharmacodynamics of TS-943 for selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist in normal healthy subjectsA Furuya, N Kato, S Jingu, et al.
Pageof 30

Showing results (191-200 of 299) with videos related to

Sort By:
Pageof 30
Genes, Chromosomes & Cancer|October 28, 1998
Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancersK Ohgaki, A Iida, F Kasumi, et al.
Arzneimittel-Forschung|April 1, 1986
Intestinal absorption enhancement of coenzyme Q10 with a lipid microsphereY Ozawa, Y Mizushima, I Koyama, et al.
Cancer Detection and Prevention|January 1, 1986
Assessment of host immune response in breast cancer patientsM Akimoto, H Ishii, Y Nakajima, et al.
Biochemical Pharmacology|January 22, 2000
Modulation of telomerase activity by zinc in human prostatic and renal cancer cellsK Nemoto, Y Kondo, S Himeno, et al.
IUBMB Life|January 19, 2000
Effect of 13-hydroperoxyoctadecadienoic acid on the supply of arachidonic acid for prostaglandin synthesis from arachidonoyl-CoA mediated by the cytosolic or microsomal acyl-CoA hydrolase in rabbit kidney medullaS Sakuma, Y Fujimoto, M Yoshimura, et al.
Nihon Geka Gakkai Zasshi|January 1, 1991
[Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors]M Akimoto, T Nishihira, H Hirakawa, et al.
Urology|August 30, 2000
High-frequency endoluminal ultrasonography for staging transitional cell carcinoma of the bladderK Horiuchi, N Tsuboi, H Shimizu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1984
[Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)]M Akimoto, H Ueki, Y Nakajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[The effect of an arginine-imbalanced diet on the growth of implanted MM-48 and MH-134 tumors in C3H/He mice]M Akimoto, Y Nakajima, H Iwasaki, et al.
Clinical Pharmacology and Therapeutics|May 29, 2000
Population pharmacokinetics and pharmacodynamics of TS-943 for selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist in normal healthy subjectsA Furuya, N Kato, S Jingu, et al.
Pageof 30